company
UCB Biosciences Inc.
Jurisdiction: US
FDA Warning Letter timeline
V1 scope: FDA Warning Letters only. Additional public-record sources (SEC, CPSC, federal contracts) are on the V2 roadmap and are not surfaced here today.
- fda_recall · drug_recall2026-05-27UCB Biosciences Inc. — Class II recall: cimzia (certolizumab pegol), 2x200mg/mL PREFILLED SYRINGES (2 single-dose), Rx O…
Frequently asked questions
- How many FDA warning letters has UCB Biosciences Inc. received?
- Argus HQ has not recorded an FDA warning letter for UCB Biosciences Inc. in our current dataset.
- What FDA recalls has UCB Biosciences Inc. issued?
- Argus HQ has recorded 1 FDA recall tied to UCB Biosciences Inc..
- Is UCB Biosciences Inc. FDA compliant?
- Argus HQ is not a compliance rating service. As of this page's last update, our dataset shows 0 warning letters, 1 recall, and 0 approval records for UCB Biosciences Inc.. Review the linked FDA source records directly before drawing a compliance conclusion.
Informational only. FDA Warning Letters are public records (17 USC §105). Summaries are AI-assisted and may contain errors; always verify against the original FDA letter before acting. Not legal, financial, or regulatory advice.

